Sonus’s ultrasound AI platform will power a point-of-care test that enables frontline clinicians to better assess placental health and flag pregnancies at risk of fetal hypoxia.

Investment to support clinical studies of Sonus Microsystem’s wearable ultrasound patch FOR IMMEDIATE RELEASE: October 23, 2025 VANCOUVER, British Columbia: Providence Health Care Ventures (PHCV), a strategic catalyst for health care innovation, announced today a strategic investment in Sonus Microsystems , a leader in innovative ultrasound technology, alongside angel investors including physicians in the cardiac care field. PHCV's investment marks a significant milestone in the...

Sonus Microsystems, developers of an AI-powered ultrasound wearable for autonomous on-demand ultrasound, today announced the company has entered a Collaboration Agreement with Kinetix Medicine (“Kinetix”).